Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1991 Jan 1;173(1):101–109. doi: 10.1084/jem.173.1.101

Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells

PMCID: PMC2118770  PMID: 1985117

Abstract

Recipient-antidonor alloreactivity before HLA genotypically identical bone marrow transplantation (BMT) between donor-recipient pairs that are negative in the mixed lymphocyte reaction (MLR), the cell-mediated lympholysis (CML) assay, and the lymphocyte crossmatch was not detectable in the majority of cases, using recipient peripheral blood lymphocytes (PBL) collected before BMT as responder cells and donor PBL as stimulator cells. However, when donor bone marrow mononuclear cells (BMMNC) instead of PBL were used as stimulator cells, we could detect donor-specific alloreactivity in 7 of 10 HLA genotypically identical donor-recipient pairs. To demonstrate that this alloreactivity was minor histocompatibility (mH) antigen specific and not directed against HLA class I splits or variants, two cytotoxic T lymphocyte (CTL) lines were tested in further detail against phytohemagglutinin (PHA) blasts from pairs of HLA genotypically identical siblings positive for the HLA class I restriction molecule. Both CTL lines recognized mH antigens, as illustrated by the differential recognition of PHA blasts of one of the two siblings from several pairs. The potential role of these mH antigen- specific CTLs in bone marrow graft rejection was demonstrated by the mH antigen-specific growth inhibition of hematopoietic progenitor cells from the original bone marrow donor and from HLA class I restriction molecule-positive individuals who expressed the mH antigens on their PBL and BMMNC. Our assay can be used in HLA genotypically identical BMT to detect a recipient-antidonor response, directed against cellularly defined mH antigens expressed on donor HPC, BMMNC, and PBL, before transplantation.

Full Text

The Full Text of this article is available as a PDF (860.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anasetti C., Amos D., Beatty P. G., Appelbaum F. R., Bensinger W., Buckner C. D., Clift R., Doney K., Martin P. J., Mickelson E. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989 Jan 26;320(4):197–204. doi: 10.1056/NEJM198901263200401. [DOI] [PubMed] [Google Scholar]
  2. Bordignon C., Keever C. A., Small T. N., Flomenberg N., Dupont B., O'Reilly R. J., Kernan N. A. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms. Blood. 1989 Nov 1;74(6):2237–2243. [PubMed] [Google Scholar]
  3. Bosserman L. D., Murray C., Takvorian T., Anderson K. C., Freedman A. S., Fitzsimmons J., Coral F., Nadler L. M., Schlossman S. F., Ritz J. Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients. Bone Marrow Transplant. 1989 May;4(3):239–245. [PubMed] [Google Scholar]
  4. Brand A., Claas F. H., Falkenburg J. H., van Rood J. J., Eernisse J. G. Blood component therapy in bone marrow transplantation. Semin Hematol. 1984 Apr;21(2):141–155. [PubMed] [Google Scholar]
  5. Brand A., Claas F. H., Voogt P. J., Wasser M. N., Eernisse J. G. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions. Vox Sang. 1988;54(3):160–166. doi: 10.1111/j.1423-0410.1988.tb03892.x. [DOI] [PubMed] [Google Scholar]
  6. Bunjes D., Heit W., Arnold R., Schmeiser T., Wiesneth M., Carbonell F., Porzsolt F., Raghavachar A., Heimpel H. Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation. 1987 Apr;43(4):501–505. doi: 10.1097/00007890-198704000-00009. [DOI] [PubMed] [Google Scholar]
  7. Butturini A., Seeger R. C., Gale R. P. Recipient immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation. Blood. 1986 Oct;68(4):954–956. [PubMed] [Google Scholar]
  8. Claas F. H., van Rood J. J., Warren R. P., Weiden P. L., Su P. J., Storb R. The detection of non-HLA antibodies and their possible role in bone marrow graft rejection. Transplant Proc. 1979 Mar;11(1):423–426. [PubMed] [Google Scholar]
  9. Falkenburg J. H., Fibbe W. E., van der Vaart-Duinkerken N., Nichols M. E., Rubinstein P., Jansen J. Human erythroid progenitor cells express Rhesus antigens. Blood. 1985 Sep;66(3):660–663. [PubMed] [Google Scholar]
  10. Falkenburg J. H., van der Vaart-Duinkerken N., Veenhof W. F., Goselink H. M., van Eeden G., Parlevliet J., Jansen J. Complement-dependent cytotoxicity in the analysis of antigenic determinants on human hematopoietic progenitor cells with HLA-DR as a model. Exp Hematol. 1984 Dec;12(11):817–821. [PubMed] [Google Scholar]
  11. Fitchen J. H., Gale R. P., Cline M. J. Serum inhibitors of in vitro hematopoiesis and graft outcome in bone marrow transplantation for aplastic anemia. Transplantation. 1980 Mar;29(3):223–226. doi: 10.1097/00007890-198003000-00012. [DOI] [PubMed] [Google Scholar]
  12. Goulmy E. Class-I-restricted human cytotoxic T lymphocytes directed against minor transplantation antigens and their possible role in organ transplantation. Prog Allergy. 1985;36:44–72. [PubMed] [Google Scholar]
  13. Goulmy E., Gratama J. W., Blokland E., Zwaan F. E., van Rood J. J. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature. 1983 Mar 10;302(5904):159–161. doi: 10.1038/302159a0. [DOI] [PubMed] [Google Scholar]
  14. Gratwohl A., Tichelli A., Würsch A., Dieterle A., Lori A., Thomssen C., Baldomero H., de Witte T., Nissen C., Speck B. Irradiated donor buffy coat following T cell-depleted bone marrow transplants. Bone Marrow Transplant. 1988 Nov;3(6):577–582. [PubMed] [Google Scholar]
  15. Hale G., Cobbold S., Waldmann H. T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation. Transplantation. 1988 Apr;45(4):753–759. doi: 10.1097/00007890-198804000-00018. [DOI] [PubMed] [Google Scholar]
  16. Hill R. S., Petersen F. B., Storb R., Appelbaum F. R., Doney K., Dahlberg S., Ramberg R., Thomas E. D. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood. 1986 Mar;67(3):811–816. [PubMed] [Google Scholar]
  17. Kaminski E., Hows J., Man S., Brookes P., Mackinnon S., Hughes T., Avakian O., Goldman J. M., Batchelor J. R. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation. 1989 Oct;48(4):608–613. [PubMed] [Google Scholar]
  18. Kedar E., Or R., Naparstek E., Zeira E., Slavin S. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT). Bone Marrow Transplant. 1988 Mar;3(2):129–140. [PubMed] [Google Scholar]
  19. Kurtzman G., Frickhofen N., Kimball J., Jenkins D. W., Nienhuis A. W., Young N. S. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med. 1989 Aug 24;321(8):519–523. doi: 10.1056/NEJM198908243210807. [DOI] [PubMed] [Google Scholar]
  20. Martin P. J., Hansen J. A., Storb R., Thomas E. D. Human marrow transplantation: an immunological perspective. Adv Immunol. 1987;40:379–438. doi: 10.1016/s0065-2776(08)60243-6. [DOI] [PubMed] [Google Scholar]
  21. Opelz G., Gale R. P. Absence of specific mixed leukocyte culture reactivity during graft-versus-host disease and following bone marrow transplant rejection. Transplantation. 1976 Nov;22(5):474–477. doi: 10.1097/00007890-197611000-00010. [DOI] [PubMed] [Google Scholar]
  22. Parkman R., Rosen F. S., Rappeport J., Camitta B., Levey R. L., Nathan D. G. Detection of genetically determined histocompatibility antigen differences between HL-A identical and MLC nonreactive siblings. Transplantation. 1976 Feb;21(2):110–116. doi: 10.1097/00007890-197602000-00004. [DOI] [PubMed] [Google Scholar]
  23. Storb R., Prentice R. L., Thomas E. D., Appelbaum F. R., Deeg H. J., Doney K., Fefer A., Goodell B. W., Mickelson E., Stewart P. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br J Haematol. 1983 Dec;55(4):573–585. doi: 10.1111/j.1365-2141.1983.tb02839.x. [DOI] [PubMed] [Google Scholar]
  24. Torok-Storb B. J., Storb R., Deeg H. J., Graham T. C., Wise C., Weiden P. L., Adamson J. W. Growth in vitro of donor marrow cultured with recipient lymphocytes predicts the fate of marrow grafts in transfused DLA-identical dogs. Blood. 1979 Jan;53(1):104–108. [PubMed] [Google Scholar]
  25. Torok-Storb B., Simmons P., Przepiorka D. Impairment of hemopoiesis in human allografts. Transplant Proc. 1987 Dec;19(6 Suppl 7):33–37. [PubMed] [Google Scholar]
  26. Voogt P. J., Fibbe W. E., Marijt W. A., Goulmy E., Veenhof W. F., Hamilton M., Brand A., Zwann F. E., Willemze R., van Rood J. J. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet. 1990 Jan 20;335(8682):131–134. doi: 10.1016/0140-6736(90)90003-n. [DOI] [PubMed] [Google Scholar]
  27. Voogt P. J., Goulmy E., Fibbe W. E., Veenhof W. F., Brand A., Falkenburg J. H. Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells. J Clin Invest. 1988 Sep;82(3):906–912. doi: 10.1172/JCI113697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Voogt P. J., Goulmy E., Veenhof W. F., Hamilton M., Fibbe W. E., Van Rood J. J., Falkenburg J. H. Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells. J Exp Med. 1988 Dec 1;168(6):2337–2347. doi: 10.1084/jem.168.6.2337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Warren R. P., Storb R., Thomas E. D. Immunological studies in patients with aplastic anemia who rejected marrow grafts from HLA-identical sibling donors. Transplantation. 1982 Nov;34(5):280–283. doi: 10.1097/00007890-198211000-00008. [DOI] [PubMed] [Google Scholar]
  30. Warren R. P., Storb R., Weiden P. L., Su P. J., Thomas E. D. Prediction of marrow graft rejection by the lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity assays. Transplantation. 1980 Aug;30(2):118–121. doi: 10.1097/00007890-198008000-00008. [DOI] [PubMed] [Google Scholar]
  31. Würsch A. M., Gratama J. W., Middeldorp J. M., Nissen C., Gratwohl A., Speck B., Jansen J., D'Amaro J., The T. H., De Gast G. C. The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. Clin Exp Immunol. 1985 Nov;62(2):278–287. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES